 SAN JOSE, Calif., Nov. 10, 2020 GLOBE NEWSWIRE -- AnPac Bio-Medical Science Co., Ltd. AnPac Bio, the Company or we NASDAQ: ANPC, a biotechnology company with operations in China and the United States announced today that the Company has completed an FDA EUA- SARS-CoV-2 COVID-19 antibody test verification in its San Jose, California lab in November 2020 for the Roche Elecsys Anti Sars-COV-2 test, and is now capable of entering into the commercial testing stage. The Company also announced that COVID-19 antibody test equipment has also completed installation in its Philadelphia lab. 